Melanoma identification
Showing 1 - 25 of 7,010
Whack-a-Mole: TestingIntervention to Increase Melanoma
Completed
- Diagnoses Disease
- ABCD Information
- +3 more
-
Coral Gables, FloridaUniversity of Miami
Oct 15, 2021
Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsense™ VS3 - Stereoscopic High Definition Visualisation System
Completed
- Malignant Melanoma
- Merkel Cell Carcinoma
- Visionsense™ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
-
Bern, Kanton Bern, SwitzerlandInselspital, University Hospital Bern, University of Bern
Dec 7, 2022
Melanoma Trial ([U-13C]Glucose Infusion)
Not yet recruiting
- Melanoma
- [U-13C]Glucose Infusion
- (no location specified)
Oct 6, 2022
Non-Small Cell Bronchopulmonary Carcinoma or Melanoma Trial in Nice (18FDG PET)
Recruiting
- Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
- 18FDG PET
-
Nice, FranceCentre Antoine Lacassagne
Sep 13, 2022
Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear
Recruiting
- Breast Carcinoma
- +9 more
- Indocyanine green
- +3 more
-
Vandoeuvre-les-Nancy, FranceInstitut de Cancérologie de Lorraine
Mar 29, 2022
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma
Active, not recruiting
- Choroidal Nevi, Uveal Melanoma
-
Houston, Texas
- +2 more
Mar 24, 2021
Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune
Recruiting
- Metastatic Melanoma
- +3 more
- Immune checkpoint inhibitor
-
Ljubljana, SloveniaInstitute of Oncology Ljubljana
May 17, 2023
Uveal Melanoma Trial in Vienna (any therapy suitable)
Recruiting
- Uveal Melanoma
- any therapy suitable
-
Vienna, AustriaMedical University of Vienna
Feb 8, 2023
Profiling of Circulating Immune Cells to Uncover Response
Not yet recruiting
- Melanoma
- (no location specified)
Nov 23, 2023
Morphological, Genetic and Tumour Microenvironment
Recruiting
- Uveal Melanoma
- cytogenetic analysis on tumour tissue
- Digital Pathology
-
Rome, ItalyMonica Maria Pagliara - Oncologia Oculare
May 26, 2023
Clinical, Laboratory, and Epidemiologic Characterization of
Recruiting
- Melanoma
- Dysplastic Nevus Syndrome
-
Bethesda, Maryland
- +1 more
Jan 18, 2023
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Completed
- Metastatic Melanoma
- +3 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))
Not yet recruiting
- Stage II Melanoma
- Relatlimab and nivolumab fixed dose combination (FDC)
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Oct 26, 2022
Cutaneous Melanoma Trial in Portland (Training and Education)
Not yet recruiting
- Cutaneous Melanoma
- Training and Education
-
Portland, OregonOHSU Knight Cancer Institute
Dec 29, 2022
Advanced Melanoma
Enrolling by invitation
- Melanoma
- observational
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Phase of Uveal Melanoma: A Prospective Multi-method Study
Not yet recruiting
- Uveal Melanoma
- Questionnaires and interviews
- (no location specified)
Oct 4, 2023
Melanoma Trial (Blood samples, Skin biopsy)
Not yet recruiting
- Melanoma
- Blood samples
- Skin biopsy
- (no location specified)
Oct 3, 2022
NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic
Not yet recruiting
- NSCLC
- +5 more
- single fraction stereotactic radiosurgery (SSRS)
- fractionated stereotactic radiosurgery (FSRS)
- (no location specified)
Jan 18, 2023
Covid-19, Lung Cancer Trial in Spain
Completed
- Covid-19
- Lung Cancer
-
Ferrol, A Coruña, Spain
- +74 more
Jun 21, 2022
Predictive Parameters for Colitis in Melanoma Patients Treated
Completed
- Melanoma
- Colitis
-
Groningen, NetherlandsUMCG
Apr 1, 2019
Molecular Markers and Therapeutic Implications
Active, not recruiting
- Melanoma
-
Athens, Greece1st Dept of Medical Oncology, Metropolitan Hospital
Mar 29, 2022
Malignant Melanoma, NSCLC, Renal Cell Cancer Trial in United Kingdom (ImmuniCell®)
Terminated
- Malignant Melanoma
- +2 more
- ImmuniCell®
-
Cardiff, United Kingdom
- +6 more
Mar 8, 2022
Targeted Therapies in BRAF Positive Metastatic Melanoma in US
Active, not recruiting
- Melanoma
- Encorafenib
- +5 more
-
New York, New YorkPfizer Investigational Site
Feb 18, 2022
DermTech's Non-Invasive Pigmented Lesion Assay to Detect and
Completed
- Melanoma Detection
- Repeat Testing
-
San Diego, CaliforniaWest Dermatology
Mar 24, 2021